CD200R1 and B-cell chronic lymphocytic leukemia: Released sCD200 is able to engage CD200R1, inducing intracellular signaling, and it has been reported that sCD200 is able to promote CLL cells’ growth in immunodeficient mice, in a process that critically involves T cells [20].